Filing Details
- Accession Number:
- 0001562180-16-002763
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-07-05 16:05:34
- Reporting Period:
- 2016-07-01
- Filing Date:
- 2016-07-05
- Accepted Time:
- 2016-07-05 16:05:34
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1192448 | Glaukos Corp | GKOS | Surgical & Medical Instruments & Apparatus (3841) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1644557 | William Thomas Burns | C/O Glaukos Corporation 20651 Merit Circle, Suite 103 Laguna Hills CA 92653 | Chief Executive Officer | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2016-07-01 | 50,000 | $29.12 | 462,254 | No | 4 | S | Indirect | Through the Burns Family Trust |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Indirect | Through the Burns Family Trust |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 1,388 | Direct | |
Common Stock | 238,107 | Indirect | Through the Burns Annuity Trust |
Common Stock | 120,000 | Indirect | Through the Burns Charitable Remainder Trust |
Common Stock | 100,000 | Indirect | Through the Janet M. Burns Irrevocable Trust |
Common Stock | 100,000 | Indirect | Through the Thomas W. Burns Irrevocable Trust |
Footnotes
- These trades were made pursuant to a Rule 10b5-1 trading plan with pre-determined share amounts and prices.
- This transaction was executed in multiple trades at prices ranging from $28.78 to $29.43. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.